Analysts who follow NeoGenomics, Inc. (NEO) on average expect it to gain 33.58% over the next twelve months. Those same analysts give the stock an average rating of Strong Buy.
That average rating earns the stock an Analyst Ranking of 70, which means it ranks higher than 70 of stocks, based on data compiled by InvestorsObserver.
Wall Street analysts are rating NEO a Strong Buy today. Find out what this means to you and get the rest of the rankings on NEO!
Though analyst projections should not be your only resource when determining your position on a stock, it can be a very useful tool. Analysts follow sectors/industries in-depth and tend to know how local and global conditions tend to affect demand and prices. Many analysts even participate in conference calls where they can get information to better make sense of the numbers.
InvestorsObserver averages the ratings provided by analysts and then ranks their score as a percent against the market. This allows you to compare stocks in a more comprehensive fashion than with the typical buy/sell/hold ranking.
What's Happening With NeoGenomics, Inc. Stock Today?
NeoGenomics, Inc. (NEO) stock is trading at $42.67 as of 11:10 AM on Monday, Nov 8, an increase of $1.29, or 3.12% from the previous closing price of $41.38. The stock has traded between $40.74 and $43.12 so far today. Volume today is low. So far 283,493 shares have traded compared to average volume of 1,115,347 shares.
Click Here to get the full Stock Report for NeoGenomics, Inc. stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
